Capecitabine in the treatment of metastatic colorectal cancer.

被引：0
|
作者：
Brockmann, B [1 ]
Magacz, A [1 ]
Bierig, S [1 ]
Kraube, K [1 ]
机构：
[1] Onkol Klin Humaine, Dresden, Germany
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
239
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] Phase I trial of thalidomide and capecitabine for treatment of metastatic colorectal cancer.
    Goldstein, MJ
    Leighton, JC
    Chapman, A
    Carberry, M
    Mitchell, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 292S - 292S
  • [2] A phase II study of oxaliplatin, capecitabine and bevacizumab in the treatment of metastatic colorectal cancer.
    Fernando, N
    Yu, D
    Morse, M
    Blobe, G
    Odogwu, L
    Crews, J
    Polito, A
    Honeycutt, W
    Franklin, A
    Hurwitz, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 260S - 260S
  • [3] Capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.
    McCollum, AD
    Wu, B
    Clark, J
    Kulke, M
    Enzinger, P
    Ryan, D
    Earle, C
    Michelini, A
    Fuchs, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 283S - 283S
  • [4] Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy
    Koukourakis, G.
    Kouloulias, V.
    Zacharias, G.
    Koukourakis, M.
    JOURNAL OF BUON, 2010, 15 (04): : 652 - 659
  • [5] A phase II trial of celecoxib, irinotecan, and capecitabine in metastatic colorectal cancer.
    El-Rayes, BF
    Zalupski, MM
    Shields, AF
    Heilbrun, LK
    Bekaii-Saab, T
    Vaishampayan, U
    Philip, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 290S - 290S
  • [6] A phase II study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer.
    Bendell, J. C.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Schaffer, S.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 156S - 156S
  • [7] A phase I/II study of nintedanib and capecitabine in refractory metastatic colorectal cancer.
    Boland, Patrick McKay
    Fakih, Marwan
    Attwood, Kristopher
    Robins, Melissa
    Iyer, Renuka V.
    Ma, Wen Wee
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] A phase I/II study of nintedanib and capecitabine in refractory metastatic colorectal cancer.
    Boland, Patrick McKay
    Fakih, Marwan
    Lim, Dean
    Attwood, Kristopher
    Tan, Wei
    Mastri, Michalis
    Bies, Robert
    Fountzilas, Christos
    Iyer, Renuka V.
    Ma, Wen Wee
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Perifosine and capecitabine in metastatic colorectal cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (01): : E5 - E5
  • [10] Apatinib as a salvage treatment for refractory metastatic colorectal cancer.
    Chen, Xiaofeng
    Li, Ping
    Sun, Jing
    Wang, Biao
    Lin, Peinan
    Cai, Xiaomin
    Han, Xiao
    Gu, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345